Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Hinyokika Kiyo ; 65(8): 333-336, 2019 Aug.
Article in Japanese | MEDLINE | ID: mdl-31501402

ABSTRACT

Angiosarcoma is a very rare tumor. The malignancy is high grade and the prognosis is extremely poor. A 51-year-old man was admitted to our hospital with the main complaint of asymptomatic macroscopic hematuria. Since right ureteral cancer was suspected by the imaging examination, laparoscopic right total nephroureterectomy was planned. However, strong adhesion was found between the tumor and the surrounding tissue, and the tumor could not be completely resected from the distal ureter. Pathological diagnosis was primary ureteral angiosarcoma, and staging was right middle ureteral angiosarcoma T3N0M0. However, since surgical findings strongly suspected that the peeled surface was positive, adjuvant radiation therapy was added. He is alive without disease recurrence at one year and eight months after surgery.


Subject(s)
Hemangiosarcoma , Ureter , Ureteral Neoplasms , Hemangiosarcoma/diagnosis , Hemangiosarcoma/surgery , Humans , Male , Middle Aged , Neoplasm Recurrence, Local , Nephroureterectomy , Ureteral Neoplasms/diagnosis , Ureteral Neoplasms/surgery
2.
Nihon Hinyokika Gakkai Zasshi ; 109(3): 140-143, 2018.
Article in Japanese | MEDLINE | ID: mdl-31327854

ABSTRACT

Primary bladder amyloidosis is a rare disease, with approximately 200 cases documented in the literature. We herein present a 85-year-old Japanese man who has undergone a transurethral resection of a bladder tumor (TURBT) and has regularly been followed up after surgery. Since cystoscopy revealed mucosal irregularity, he has got a TURBT again for a suspicion of recurrence. There were no malignant findings in pathological diagnosis and we diagnosed as amyloidosis because it showed positive by Congo-red staining. We added immunohistological diagnosis to diagnose as localized AL amyloidosis of the bladder finally.

3.
J Med Case Rep ; 11(1): 297, 2017 Oct 20.
Article in English | MEDLINE | ID: mdl-29052535

ABSTRACT

BACKGROUND: Primary large cell neuroendocrine carcinoma of the kidney is a rare and generally very aggressive disease. We present a case of a patient with primary large cell neuroendocrine carcinoma of the kidney with cardiac metastasis. CASE PRESENTATION: A 59-year-old Japanese man presented to his previous physician with hematuria. Computed tomography revealed masses in the heart and right kidney, and fluorodeoxyglucose-positron emission tomography showed abnormal uptake in the heart. A cardiac biopsy under transesophageal echocardiographic guidance revealed a metastatic tumor. Subsequently, multiple lung lesions were detected, and a right nephrectomy was performed after these metastases were suspected to have originated from renal carcinoma. Large cell neuroendocrine carcinoma of the kidney was ultimately diagnosed. Pancreatic metastasis was detected on computed tomography postoperatively. Three courses of chemotherapy with carboplatin and irinotecan were administered, and were temporarily effective against the metastatic lesions in the lungs and pancreas. However, our patient's general condition deteriorated with the progression of the lesions, and he died 9 months after his initial examination. CONCLUSIONS: Multi-agent chemotherapy, including platinum-based drugs was effective against large cell neuroendocrine carcinoma metastases, albeit only temporarily. This is the first reported case of large cell neuroendocrine carcinoma with cardiac metastasis.


Subject(s)
Carcinoma, Neuroendocrine/pathology , Heart Neoplasms/secondary , Kidney Neoplasms/pathology , Neoplasms, Second Primary/diagnostic imaging , Biopsy/methods , Fatal Outcome , Heart/diagnostic imaging , Humans , Kidney/diagnostic imaging , Kidney/pathology , Male , Middle Aged , Myocardium/pathology , Neoplasms, Second Primary/pathology , Positron-Emission Tomography/methods , Tomography, X-Ray Computed/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...